AHA yesterday expressed concern that certain enforcement mechanisms contemplated for health care providers to further interoperability in the 21st Century Cures legislation are inappropriate and could have significant unintended consequences. “We appreciate the inclusion of provisions to further interoperability in Subtitle A of Title III of the 21st Century Cures legislation,” AHA Executive Vice President Rick Pollack said in a letter to the House Energy and Commerce Committee. “However, we are concerned that the heavy-handed and duplicative enforcement mechanisms contemplated for providers could have significant unintended consequences, including undermining new models of care and setting up an environment where well-intentioned providers face significant penalties for small mistakes.” He added, “We appreciate your intent to hold vendors accountable for the design and marketing of interoperable products, and recommend that you ask the Federal Trade Commission to conduct a study of anti-competitive behavior by EHR vendors.” In addition, he said, “we still lack significant technical capabilities and infrastructure to support efficient and effective health information exchange. We believe that there are positive steps that would further our shared goals, such as more robust testing of health information technology products and greater commitment to developing and maturing data standards.”

Related News Articles

Headline
The Senate Committee on Health, Education, Labor and Pensions today held a hearing on the Lower Health Care Costs Act, its draft legislation to prevent…
Headline
The AHA said it is generally supportive of the overall concept of the agreement and agency’s goal to create a voluntary network-of-networks that would enable…
Headline
AHA's Physician Alliance will host a webinar on how artificial intelligence technology is being used to optimize practice and reduce clinician burden
Headline
The Centers for Disease Control and Prevention this week announced an anticipated shortage of Aplisol, one of two TB skin tests licensed by the Food and Drug…
Headline
The Centers for Medicare…
Headline
The AHA today shared with the Centers for Medicare…